A chief fellow in hematology and medical oncology from the Oregon Health and Science University, Natasha Tiffany, MD is a physician and business partner at Oregon Oncology Specialists. Natasha Tiffany, MD is heavily involved in the advances in cancer care, especially immunotherapy and personalized cancer medicine.
Personalized cancer medicine is one of the latest advances in the management and treatment of cancer. The customized aspect is that the medication and care are tailored to your genetic disposition, specific disease, and other unique identifiers. The genetic information instructs the body cells how to develop, grow, divide, and have longevity. In this aspect, some cancers target specific genes. This knowledge helps researchers formulate customized treatment regimens and develop more effective tests, prevention and diagnosis measures. Precise targeting means fewer side effects than other modes of treatment. Also, the doctors, especially the family physicians, have a chance of learning your susceptibility to developing cancer, and thus schedule screening tests early and engage mitigation measures on time. Lastly, the vulnerability enables doctors to gauge the risk of recurrence and integrate efforts to prevent cancer from returning. Before personalized medication, cancer patients all received the same treatment and management regimens. There was noticeable treatment effectiveness in some people, while others had severe side effects. Research pointed towards genetic differences as the primary variable in the variation. Examples of personalized cancer medicine include targeted therapy and pharmacogenetics. The latter is research on how genes affect the body’s response to drugs.
0 Comments
Leave a Reply. |
AuthorNatasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state’s capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division. Archives
October 2019
Categories
All
|